Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mangrove Partners Cuts Stake in Biota Pharmaceuticals

Nathaniel August‘s Mangrove Partners has reported, in a recent filing with the SEC, that it no longer is an owner of more than 5% of the common stock of Biota Pharmaceuticals Inc (NASDAQ:BOTA). Mangrove Partners now owns only 176 shares of the company.


Disclosure: none

Recommended reading:

Jim Simons’ Latest Strategy is ‘Out With the New, In With the Old’

Ray Dalio, Bridgewater Make Micron New Top Dog, Love Tech Blue Chips

BlueMountain Unhappy With Chatham Takeover Rejection